Evidence map›Paper›PMID 28494781›Full record

ArticleBiomedical engineering online2017

Preparation and characterization of small-diameter decellularized scaffolds for vascular tissue engineering in an animal model.

Shuangyue Xu, Fangna Lu, Lianna Cheng, Chenglin Li, Xu Zhou, Yuan Wu, Hongxing Chen, Kaichuang Zhang, Lumin Wang, Junjie Xia and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomedical engineering online, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Tissue compliance characterization for human umbilical arteries after decellularization.Journal of the mechanical behavior of biomedical materials · 2026
    Article
  2. Article
  3. Review
  4. The journey of decellularized vessel: from laboratory to operating room.Frontiers in bioengineering and biotechnology · 2024
    Review
  5. From waste to wealth: Repurposing slaughterhouse waste for xenotransplantation.Frontiers in bioengineering and biotechnology · 2023
    Article
  6. Article
  7. Review
  8. Monocyte Recruitment for Vascular Tissue Regeneration.Advanced healthcare materials · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Yak Pericardium as an Alternative Biomaterial for Transcatheter Heart Valves.Frontiers in bioengineering and biotechnology · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  20. Building Blood Vessels with Vascular Progenitor Cells.Trends in molecular medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Shuangyue XuOrgan Transplantation Institute of Xiamen University, Xiamen, 361102, Fujian Province, People's Republic of China.
Fangna LuOrgan Transplantation Institute of Xiamen University, Xiamen, 361102, Fujian Province, People's Republic of China.
Lianna ChengOrgan Transplantation Institute of Xiamen University, Xiamen, 361102, Fujian Province, People's Republic of China.
Chenglin LiOrgan Transplantation Institute of Xiamen University, Xiamen, 361102, Fujian Province, People's Republic of China.
Xu ZhouMedical College, Xiamen University, Xiamen, 361000, Fujian Province, People's Republic of China.
Yuan WuCardiovascular Surgery, Heart CenterXiamen University Affiliated Zhongshan Hospital, Xiamen City, 361000, Fujian Province, People's Republic of China.
Hongxing ChenMedical College, Xiamen University, Xiamen, 361000, Fujian Province, People's Republic of China.
Kaichuang ZhangDepartmant of Neurosurgery, Fuzhou Second Affiliated Hospital of Xiamen University, Fuzhou, 350007, Fujian Province, People's Republic of China.
Lumin WangOrgan Transplantation Institute of Xiamen University, Xiamen, 361102, Fujian Province, People's Republic of China.
Junjie XiaOrgan Transplantation Institute of Xiamen University, Xiamen, 361102, Fujian Province, People's Republic of China.
Guoliang YanOrgan Transplantation Institute of Xiamen University, Xiamen, 361102, Fujian Province, People's Republic of China. zhuanyiyan@126.com.
Zhongquan QiOrgan Transplantation Institute of Xiamen University, Xiamen, 361102, Fujian Province, People's Republic of China. oti@xmu.edu.cn.
Xiamen University · CNFuzhou Second Hospital · CNZhongshan Hospital of Xiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe development of a suitable extracellular matrix (ECM) scaffold is the first step in vascular tissue engineering (VTE). Synthetic vascular grafts are available as an alternative to autologous vessels in large-diameter arteries (>8 mm) and medium-diameter arteries (6-8 mm). In small-diameter vessels (<6 mm), synthetic vascular grafts are of limited use due to poor patency rates. Compared with a vascular prosthesis, natural tissue ECM has valuable advantages. Despite considerable progress in recent years, identifying an optimal protocol to create a scaffold for use in small-diameter (<6 mm) fully natural tissue-engineered vascular grafts (TEVG), remains elusive. Although reports on different decellularization techniques have been numerous, combination of and comparison between these methods are scarce; therefore, we have compared five different decellularization protocols for making small-diameter (<6 mm) ECM scaffolds and evaluated their characteristics relative to those of fresh vascular controls.

resultsThe protocols differed in the choice of enzymatic digestion solvent, the use of non-ionic detergent, the durations of the individual steps, and UV crosslinking. Due to their small diameter and ready availability, rabbit arteria carotis were used as the source of the ECM scaffolds. The scaffolds were subcutaneously implanted in rats and the results were evaluated using various microscopy and immunostaining techniques.

conclusionsOur findings showed that a 2 h digestion time with 1× EDTA, replacing non-ionic detergent with double-distilled water for rinsing and the application of UV crosslinking gave rise to an ECM scaffold with the highest biocompatibility, lowest cytotoxicity and best mechanical properties for use in vivo or in situ pre-clinical research in VTE in comparison.

Indexed as

Blood Vessel ProsthesisTissue ScaffoldsAnimalsArteriesCell-Free SystemEquipment DesignEquipment Failure AnalysisExtracellular MatrixMaleNeovascularization, PhysiologicRabbitsRatsRats, Sprague-DawleyTissue EngineeringArterial tissue engineeringBiocompatibilityBlood vessel decellularizationRabbit arteria carotis

Identifiers

PMID28494781
PMCPMC5425976
OpenAlexW2612232971

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.